171 related articles for article (PubMed ID: 8529076)
1. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
[TBL] [Abstract][Full Text] [Related]
2. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
Kater CE; Biglieri EG
Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
[TBL] [Abstract][Full Text] [Related]
3. Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide.
Wu KD; Liao TS; Chen YM; Lai MK; Chen SJ; Su CT; Chu TS; Chang CC; Hsieh BS
J Formos Med Assoc; 2001 Sep; 100(9):598-603. PubMed ID: 11695274
[TBL] [Abstract][Full Text] [Related]
4. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
5. [The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism].
Shimizu Y
Nihon Naibunpi Gakkai Zasshi; 1984 Jan; 60(1):1-15. PubMed ID: 6745468
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
[TBL] [Abstract][Full Text] [Related]
7. Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism.
Shimizu Y; Hanew K; Sato S; Sasaki A; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1984 Sep; 144(1):33-42. PubMed ID: 6506061
[TBL] [Abstract][Full Text] [Related]
8. A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
Demura R; Naruse M; Isawa M; Onoda N; Naruse K; Yamakado M; Demura H
Endocrinol Jpn; 1992 Apr; 39(2):169-76. PubMed ID: 1396349
[TBL] [Abstract][Full Text] [Related]
9. Effect of naloxone on the adrenal cortex in primary aldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
Sergev O; Rácz K; Varga I; Kiss R; Fütö L; Gutkowska J; Gláz E
Clin Exp Hypertens A; 1991; 13(3):409-23. PubMed ID: 1832596
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
12. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
13. [The effects of metoclopramide and dopamine on aldosterone secretion in cultured adrenocortical adenoma cells and adjacent non-adenoma cells from patients with primary aldosteronism].
Yanase T; Nawata H; Higuchi K; Kato K; Ibayashi H
Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):631-41. PubMed ID: 4054405
[TBL] [Abstract][Full Text] [Related]
14. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
Kater CE; Biglieri EG; Schambelan M; Arteaga E
Hypertension; 1983; 5(6 Pt 3):V115-21. PubMed ID: 6360878
[TBL] [Abstract][Full Text] [Related]
15. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
16. [Primary hyperaldosteronism].
Opocher G; Rocco S; Carpené G; Armanini D; Mantero F
Minerva Endocrinol; 1995 Mar; 20(1):49-54. PubMed ID: 7651282
[TBL] [Abstract][Full Text] [Related]
17. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
18. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
[TBL] [Abstract][Full Text] [Related]
20. Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat.
Sowers JR; Golub M; Tuck M; Sowers DK
Clin Exp Hypertens (1978); 1981; 3(1):1-14. PubMed ID: 7472089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]